• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在抗磷脂综合征的病理生理学中,β2-糖蛋白 I 的氧化后翻译修饰。

Oxidative post-translational modification of βeta 2-glycoprotein I in the pathophysiology of the anti-phospholipid syndrome.

机构信息

Department of Cardiology, St George Hospital, Sydney, Australia; Department of Medicine, University of NSW, Sydney, Australia.

Department of Medicine, University of NSW, Sydney, Australia; Department of Infectious Diseases, Immunology and Sexual Health, St George Hospital, Sydney, Australia.

出版信息

Free Radic Biol Med. 2018 Sep;125:98-103. doi: 10.1016/j.freeradbiomed.2018.03.048. Epub 2018 Mar 29.

DOI:10.1016/j.freeradbiomed.2018.03.048
PMID:29604397
Abstract

The anti-phospholipid syndrome (APS) is a prothrombotic autoimmune disorder characterized by either thrombosis or pregnancy complications in the setting of persistent anti-phospholipid antibodies (aPL). βeta 2-glycoprotein I (β2-GPI) is the major autoantigen in APS that binds anionic phospholipids as well as specific receptors on platelets and endothelial cells resulting in activation of prothrombotic pathways. β2-GPI consists of 5 Domains that exist in a circular or linear form, with the latter occurring after binding to anionic phospholipids. β2-GPI also undergoes dynamic posttranslational modification between oxidized and free thiol forms. The relationship between posttranslational modification and structural conformation is yet to be definitively clarified. Compared with controls, patients with the APS have higher levels of total β2-GPI and lower levels of free thiol β2-GPI. This raises the possibility of using quantification of β2-GPI posttranslational modification as a redox biomarker in the management and diagnosis of the APS.

摘要

抗磷脂综合征(APS)是一种以持续存在抗磷脂抗体(aPL)为特征的促血栓形成自身免疫性疾病,表现为血栓形成或妊娠并发症。β2-糖蛋白 I(β2-GPI)是 APS 中的主要自身抗原,它与阴离子磷脂以及血小板和内皮细胞上的特定受体结合,导致促血栓形成途径的激活。β2-GPI 由 5 个结构域组成,以环形或线性形式存在,后者发生在与阴离子磷脂结合之后。β2-GPI 还在氧化和游离巯基形式之间进行动态的翻译后修饰。翻译后修饰和结构构象之间的关系尚未得到明确阐明。与对照组相比,APS 患者的总β2-GPI 水平较高,游离巯基β2-GPI 水平较低。这提出了使用β2-GPI 翻译后修饰的定量作为 APS 管理和诊断的氧化还原生物标志物的可能性。

相似文献

1
Oxidative post-translational modification of βeta 2-glycoprotein I in the pathophysiology of the anti-phospholipid syndrome.在抗磷脂综合征的病理生理学中,β2-糖蛋白 I 的氧化后翻译修饰。
Free Radic Biol Med. 2018 Sep;125:98-103. doi: 10.1016/j.freeradbiomed.2018.03.048. Epub 2018 Mar 29.
2
Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.基于检测主要自身抗原β2-糖蛋白I的分子氧化修饰的抗磷脂综合征血栓形成致病性新检测方法。
Arthritis Rheum. 2011 Sep;63(9):2774-82. doi: 10.1002/art.30383.
3
Post-translational oxidative modification of β2-glycoprotein I and its role in the pathophysiology of the antiphospholipid syndrome.β2-糖蛋白 I 的翻译后氧化修饰及其在抗磷脂综合征病理生理学中的作用。
Autoimmun Rev. 2012 Sep;11(11):779-80. doi: 10.1016/j.autrev.2011.12.007. Epub 2011 Dec 31.
4
Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.抗磷脂抗体综合征患者体内抗β2糖蛋白I抗体
Clin Exp Immunol. 2016 May;184(2):174-82. doi: 10.1111/cei.12762. Epub 2016 Feb 15.
5
Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.合并或不合并抗磷脂综合征的HIV感染及系统性红斑狼疮中的抗磷脂抗体:磷脂特异性、亲和力及与β2-糖蛋白I反应性的比较
J Autoimmun. 1999 Nov;13(3):347-55. doi: 10.1006/jaut.1999.0324.
6
[Pathogenic roles of anti-beta2-GPI antibody in patients with antiphospholipid syndrome].抗β2糖蛋白I抗体在抗磷脂综合征患者中的致病作用
Nihon Rinsho Meneki Gakkai Kaishi. 2004 Dec;27(6):373-8. doi: 10.2177/jsci.27.373.
7
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.通过检测 IgG 抗体针对β2-糖蛋白 I 结构域 1 和结构域 4/5 对抗磷脂综合征进行临床特征分析:抗结构域 1 与抗结构域 4/5 的比值作为抗磷脂综合征的一种有用的新型生物标志物。
Arthritis Rheumatol. 2015 May;67(8):2196-204. doi: 10.1002/art.39187.
8
Carbamylation of β2-glycoprotein I generates new autoantigens for antiphospholipid syndrome: a new tool for diagnosis of 'seronegative' patients.β2-糖蛋白I的氨甲酰化产生抗磷脂综合征的新自身抗原:诊断“血清阴性”患者的新工具。
Rheumatology (Oxford). 2022 Oct 6;61(10):4187-4197. doi: 10.1093/rheumatology/keac045.
9
Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.β2-糖蛋白I通过外位点I和外位点II与凝血酶结合:抗β2-糖蛋白I抗体增强β2-糖蛋白I对凝血酶介导的因子XIa生成的抑制作用。
Arthritis Rheum. 2007 Feb;56(2):605-13. doi: 10.1002/art.22367.
10
Oxidized human beta2-glycoprotein I: its impact on innate immune cells.氧化型人β2-糖蛋白 I:对固有免疫细胞的影响。
Curr Mol Med. 2011 Dec;11(9):719-25. doi: 10.2174/156652411798062377.

引用本文的文献

1
Understanding the structure of β-glycoprotein I: new insights and future paths for antiphospholipid syndrome.了解β-糖蛋白I的结构:抗磷脂综合征的新见解与未来方向
Blood Vessel Thromb Hemost. 2024 Dec 24;2(2):100041. doi: 10.1016/j.bvth.2024.100041. eCollection 2025 May.
2
Autoimmune diseases: targets, biology, and drug discovery.自身免疫性疾病:靶点、生物学和药物发现。
Acta Pharmacol Sin. 2024 Apr;45(4):674-685. doi: 10.1038/s41401-023-01207-2. Epub 2023 Dec 14.
3
Antibodies to Domain I β-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
抗磷脂抗体综合征与系统性红斑狼疮患者中抗 I 型 β 糖蛋白 1 抗体。
Dokl Biochem Biophys. 2023 Aug;511(1):219-226. doi: 10.1134/S1607672923700278. Epub 2023 Oct 13.
4
Positive antiphospholipid antibodies: observation or treatment?抗磷脂抗体阳性:观察还是治疗?
J Thromb Thrombolysis. 2023 Aug;56(2):301-314. doi: 10.1007/s11239-023-02834-6. Epub 2023 Jun 1.
5
Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome.β2 糖蛋白 I 与中性粒细胞胞外诱捕网:抗磷脂综合征中固有免疫与适应性免疫的潜在桥梁
Front Immunol. 2023 Jan 9;13:1076167. doi: 10.3389/fimmu.2022.1076167. eCollection 2022.
6
The complement system and human autoimmune diseases.补体系统与人类自身免疫性疾病。
J Autoimmun. 2023 May;137:102979. doi: 10.1016/j.jaut.2022.102979. Epub 2022 Dec 18.
7
Managing Antiphospholipid Syndrome in Children and Adolescents: Current and Future Prospects.儿童和青少年抗磷脂综合征的管理:现状与未来展望。
Paediatr Drugs. 2022 Jan;24(1):13-27. doi: 10.1007/s40272-021-00484-w. Epub 2021 Dec 13.
8
Antiphospholipid Antibodies and Heart Failure with Preserved Ejection Fraction. The Multicenter ATHERO-APS Study.抗磷脂抗体与射血分数保留的心力衰竭。多中心动脉粥样硬化抗磷脂综合征(ATHERO-APS)研究。
J Clin Med. 2021 Jul 19;10(14):3180. doi: 10.3390/jcm10143180.
9
The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS.β2-糖蛋白 I 在健康和疾病中的作用:与结构相关的功能——不仅仅与 APS 相关。
Blood Rev. 2020 Jan;39:100610. doi: 10.1016/j.blre.2019.100610. Epub 2019 Aug 16.